Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
Abstract Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel in...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f48d2435c9aa4403b15cfc5aca00707f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f48d2435c9aa4403b15cfc5aca00707f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f48d2435c9aa4403b15cfc5aca00707f2021-12-02T15:07:44ZNon-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog10.1038/s41598-018-26444-y2045-2322https://doaj.org/article/f48d2435c9aa4403b15cfc5aca00707f2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-26444-yhttps://doaj.org/toc/2045-2322Abstract Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel inhibitors exert their effects by a dual action: they obstruct ion flow (“block”), and they alter the energetics of channel opening and closing (“modulation”). Ideal drugs would be modulators without blocking effect, because modulation is inherently activity-dependent, therefore selective for pathological hyperactivity. Can block and modulation be separated? It has been difficult to tell, because the effect of modulation is obscured by conformation-dependent association/dissociation of the drug. To eliminate dynamic association/dissociation, we used a photoreactive riluzole analog which could be covalently bound to the channel; and found, unexpectedly, that drug-bound channels could still conduct ions, although with modulated gating. The finding that non-blocking modulation is possible, may open a novel avenue for drug development because non-blocking modulators could be more specific in treating hyperactivity-linked diseases.Peter LukacsMátyás C. FöldiLuca ValánszkiEmilio CasanovaBeáta Biri-KovácsLászló NyitrayAndrás Málnási-CsizmadiaArpad MikeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Peter Lukacs Mátyás C. Földi Luca Valánszki Emilio Casanova Beáta Biri-Kovács László Nyitray András Málnási-Csizmadia Arpad Mike Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
description |
Abstract Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel inhibitors exert their effects by a dual action: they obstruct ion flow (“block”), and they alter the energetics of channel opening and closing (“modulation”). Ideal drugs would be modulators without blocking effect, because modulation is inherently activity-dependent, therefore selective for pathological hyperactivity. Can block and modulation be separated? It has been difficult to tell, because the effect of modulation is obscured by conformation-dependent association/dissociation of the drug. To eliminate dynamic association/dissociation, we used a photoreactive riluzole analog which could be covalently bound to the channel; and found, unexpectedly, that drug-bound channels could still conduct ions, although with modulated gating. The finding that non-blocking modulation is possible, may open a novel avenue for drug development because non-blocking modulators could be more specific in treating hyperactivity-linked diseases. |
format |
article |
author |
Peter Lukacs Mátyás C. Földi Luca Valánszki Emilio Casanova Beáta Biri-Kovács László Nyitray András Málnási-Csizmadia Arpad Mike |
author_facet |
Peter Lukacs Mátyás C. Földi Luca Valánszki Emilio Casanova Beáta Biri-Kovács László Nyitray András Málnási-Csizmadia Arpad Mike |
author_sort |
Peter Lukacs |
title |
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
title_short |
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
title_full |
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
title_fullStr |
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
title_full_unstemmed |
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
title_sort |
non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/f48d2435c9aa4403b15cfc5aca00707f |
work_keys_str_mv |
AT peterlukacs nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT matyascfoldi nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT lucavalanszki nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT emiliocasanova nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT beatabirikovacs nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT laszlonyitray nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT andrasmalnasicsizmadia nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog AT arpadmike nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog |
_version_ |
1718388425511403520 |